Man fatally shot in St. Paul ID’d as 20-year-old
Police have identified a man killed in a shooting on St. Paul’s West Side as a 20-year-old.
James Q. Baker, of St. Paul, died at Regions Hospital on Wednesday afternoon, soon after he was shot in an apartment complex in the 600 block of Stryker Avenue.
No one was under arrest as of Thursday afternoon. Police said Wednesday they are investigating what led to the shooting.
Baker was the first person since November to be killed in a shooting homicide in St. Paul. There have been three other homicides this year; they were each stabbings.
Related Articles
Crypto crime spills over from behind the screen to real-life violence
Pair sentenced in human smuggling case that left Indian family dead on Minnesota border
Angry with electrical utility, Iron Range official cuts wire, knocking out power to 3 towns
Authorities: Feeding Our Future suspect tried to flee after St. Paul raid
Shooting death in St. Paul is first homicide by gunfire this year
More Stories
Meta and TikTok fail to halt thousands of social media addiction lawsuits
A US appeals court has rejected a challenge by Meta and TikTok, allowing wider litigation against major platforms to proceed...
Harrods returns to £84.9m profit after Al Fayed compensation payouts
Harrods returned to a pre-tax profit of £84.9 million in the year to the end of January, according to its...
Beyoncé buys out LVMH’s stake in SirDavis whisky brand
Beyoncé has acquired full control of SirDavis, the American whisky brand she established two years ago with LVMH, after the...
87% of parents want entrepreneurial skills taught in schools
More than a third of British parents (35 per cent) would rather their child start a business than go to...
Cambridge Aerospace valued at $3.4bn after raising $300m
Defence technology company Cambridge Aerospace has raised $300 million at a valuation of $3.4 billion, two years after it was...
Rare disease investment rises after US voucher renewal, UK lags
Investment in rare disease biotechs has increased since the US Food and Drug Administration’s Rare Pediatric Disease Priority Review Voucher...